Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001213900-17-011093
Filing Date
2017-10-30
Accepted
2017-10-30 17:26:09
Documents
2
Period of Report
2017-12-20

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT pre14a1017_actinium.htm PRE 14A 775604
2 GRAPHIC image001.jpg GRAPHIC 28604
  Complete submission text file 0001213900-17-011093.txt   816241
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-36374 | Film No.: 171163384
SIC: 2834 Pharmaceutical Preparations